Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysisVijay Ramaswamy, Michael D. Taylor, Sébastien Perreault et al.|The Lancet Oncology|2013Cited by 404
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Thomas Hielscher et al.|The Lancet Oncology|2016Cited by 369